Clinical Trial Update: Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports long-term safety and efficacy evaluation of amlitelimab in participants from prior atopic dermatitis trials, with ongoing Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Amlitelimab (amlitelimab)

Snippet

Sponsor: Sanofi | Conditions: Dermatitis Atopic | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION